Update information

Update information

January 2020: This guideline is an update of NICE guideline CG131 (published November 2011) and NICE guideline CSG5 (published June 2004) and has replaced them.

Minor changes since publication

May 2021: Link added to the NICE Pathway on colorectal cancer for information on genomic biomarker-based therapy in solid tumour treatment pathways.

August 2020: A link to the NICE surveillance review of a follow-up study to the randomised controlled trial which recommendation 1.1.1 was based on was added to the rationale and impact section.

ISBN: 978-1-4731-3657-1

  • National Institute for Health and Care Excellence (NICE)